FI88397B - Foerfarande foer framstaellning av 17 -(cyklopropylamino)androst-5-en-3 -ol och naestaende foereningar, som aer anvaendbara som c17-20-lyas in hibitorer - Google Patents

Foerfarande foer framstaellning av 17 -(cyklopropylamino)androst-5-en-3 -ol och naestaende foereningar, som aer anvaendbara som c17-20-lyas in hibitorer

Info

Publication number
FI88397B
FI88397B FI881877A FI881877A FI88397B FI 88397 B FI88397 B FI 88397B FI 881877 A FI881877 A FI 881877A FI 881877 A FI881877 A FI 881877A FI 88397 B FI88397 B FI 88397B
Authority
FI
Finland
Prior art keywords
som
androst
cyclopropylamino
naestaende
hibitorer
Prior art date
Application number
FI881877A
Other languages
English (en)
Other versions
FI88397C (fi
FI881877A0 (fi
FI881877A (fi
Inventor
Michael R Angelastro
Thomas R Blohm
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI881877A0 publication Critical patent/FI881877A0/fi
Publication of FI881877A publication Critical patent/FI881877A/fi
Publication of FI88397B publication Critical patent/FI88397B/fi
Application granted granted Critical
Publication of FI88397C publication Critical patent/FI88397C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
FI881877A 1987-04-22 1988-04-21 Foerfarande foer framstaellning av 17 -(cyklopropylamino)androst-5-en-3 -ol och naestaende foereningar, som aer anvaendbara som c17-20-lyas in hibitorer FI88397C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4117287A 1987-04-22 1987-04-22
US4117287 1987-04-22

Publications (4)

Publication Number Publication Date
FI881877A0 FI881877A0 (fi) 1988-04-21
FI881877A FI881877A (fi) 1988-10-23
FI88397B true FI88397B (fi) 1993-01-29
FI88397C FI88397C (fi) 1993-05-10

Family

ID=21915133

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881877A FI88397C (fi) 1987-04-22 1988-04-21 Foerfarande foer framstaellning av 17 -(cyklopropylamino)androst-5-en-3 -ol och naestaende foereningar, som aer anvaendbara som c17-20-lyas in hibitorer

Country Status (19)

Country Link
EP (1) EP0288053B1 (fi)
JP (1) JP2711672B2 (fi)
KR (1) KR960015037B1 (fi)
CN (1) CN88102176A (fi)
AT (1) ATE67211T1 (fi)
AU (1) AU606677B2 (fi)
CA (1) CA1326234C (fi)
DE (1) DE3864725D1 (fi)
DK (1) DK217588A (fi)
ES (1) ES2038712T3 (fi)
FI (1) FI88397C (fi)
GR (1) GR3002713T3 (fi)
HU (1) HU198511B (fi)
IL (1) IL86139A (fi)
NO (1) NO169346C (fi)
NZ (1) NZ224288A (fi)
PH (1) PH24090A (fi)
PT (1) PT87294B (fi)
ZA (1) ZA882717B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5604213A (en) * 1992-03-31 1997-02-18 British Technology Group Limited 17-substituted steroids useful in cancer treatment
GB2265624B (en) * 1992-03-31 1995-04-19 British Tech Group 17-substituted steroids useful in cancer treatment
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
ES2260303T3 (es) 2000-11-17 2006-11-01 Takeda Pharmaceutical Company Limited Derivados de imidazol, metodo para su produccion, y su uso.
US6960586B2 (en) 2000-11-20 2005-11-01 Takeda Pharmaceutical Company Limited Imidazole derivatives, process for their preparation and their use
US7067537B2 (en) 2000-12-08 2006-06-27 Takeda Pharmaceutical Company Limited Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
ES2475945T3 (es) 2009-06-26 2014-07-11 Novartis Ag Derivados imidazolidin-2 -ona 1,3-disustituida como inhibidores de CYP 17
AU2011285724B2 (en) 2010-08-04 2015-01-22 Pellficure Pharmaceuticals, Inc. Combination therapy for the treatment of prostate carcinoma
CN103108871B (zh) 2010-09-16 2014-09-10 诺华股份有限公司 17α-羟化酶/C17,20-裂合酶抑制剂
BR112013027395A2 (pt) 2011-04-28 2017-01-17 Novartis Ag inibidores de 17alfa-hidroxilase/c17,20-liase
WO2014158875A1 (en) 2013-03-14 2014-10-02 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
AU2015314772B2 (en) 2014-09-12 2020-02-27 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
CA3044812A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302932A (fi) 1962-12-31
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
DK217588A (da) 1988-10-23
EP0288053B1 (en) 1991-09-11
GR3002713T3 (en) 1993-01-25
DE3864725D1 (de) 1991-10-17
KR880012633A (ko) 1988-11-28
IL86139A0 (en) 1988-11-15
EP0288053A1 (en) 1988-10-26
NO881746L (no) 1988-10-24
PT87294A (pt) 1988-05-01
JPS63284195A (ja) 1988-11-21
DK217588D0 (da) 1988-04-21
AU1471988A (en) 1988-10-27
CA1326234C (en) 1994-01-18
IL86139A (en) 1993-02-21
PH24090A (en) 1990-03-05
NO169346C (no) 1992-06-10
ATE67211T1 (de) 1991-09-15
NO881746D0 (no) 1988-04-21
JP2711672B2 (ja) 1998-02-10
KR960015037B1 (ko) 1996-10-24
HUT47307A (en) 1989-02-28
FI88397C (fi) 1993-05-10
CN88102176A (zh) 1988-11-23
NO169346B (no) 1992-03-02
AU606677B2 (en) 1991-02-14
PT87294B (pt) 1992-08-31
FI881877A0 (fi) 1988-04-21
HU198511B (en) 1989-10-30
ZA882717B (en) 1988-10-17
ES2038712T3 (es) 1993-08-01
NZ224288A (en) 1989-12-21
FI881877A (fi) 1988-10-23

Similar Documents

Publication Publication Date Title
FI88397B (fi) Foerfarande foer framstaellning av 17 -(cyklopropylamino)androst-5-en-3 -ol och naestaende foereningar, som aer anvaendbara som c17-20-lyas in hibitorer
LTIP919A (en) Drugs and process for preparing thereof
NO903564L (no) Fremgangsmaate for fremstilling av 4-substituerte 17beta-(cyklopropylamino)androst-5-en-3beta-ol-derivater.
EP0080155A3 (en) Apparatus and method for assisting respiration
ZA847193B (en) Benzothiophene derivatives as antiasthmatic agents
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ES2051787T3 (es) Un procedimiento para preparar 17beta-(ciclopropiloxi)androst-5-en-3beta-ol y compuestos relacionados.
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
FI903143A0 (fi) Menetelmä ihmisen nuhaviruksen serotyypittämiseksi
GR3024707T3 (en) Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
PT94432A (pt) Processo para a producao sulfonamidas substituidas e compostos afins uteis no tratamento da asma, artrite e doencas afins
BG50301A1 (en) Method for treatment of verbal hallucinations
IT1239345B (it) Apparecchiatura per la virbo-fluidizzazione di solidi mediante energiaacustica e procedimento relativo
AR242981A1 (es) Disposicion para el tratamiento de gas natural.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.